| Description | GPR108 Human Pre-designed siRNA Set A contains three designed siRNAs for GPR108 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GPR108 siRNA-1: 5 nmol (HPLC) GPR108 siRNA-2: 5 nmol (HPLC) GPR108 siRNA-3: 5 nmol (HPLC) siRNA Negative GPR108 Human Pre-designed siRNA Set A contains three designed siRNAs for GPR108 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GPR108 siRNA-1: 5 nmol (HPLC) GPR108 siRNA-2: 5 nmol (HPLC) GPR108 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Biochemical Test:SDS-PAGE (purity > 80%); Western blot with patient sample.Calculated Isoelectric Point:pH 5.68 | Store at +4°C. Store under desiccating conditions. The product can be stored for up to 12 months | Keratinocyte growth factor (KGF) is a cytokine found by Rubin et al. (1989) from the culture supernatant of embryonic lung fibroblasts, which is a member of the FGF family, namely FGF-7. KGF is an effective epithelial-specific growth factor secreted by mesenchymal cells and distributed in epithelialKeratinocyte growth factor (KGF) is a cytokine found by Rubin et al. (1989) from the culture supernatant of embryonic lung fibroblasts, which is a member of the FGF family, namely FGF-7. KGF is an effective epithelial-specific growth factor secreted by mesenchymal cells and distributed in epithelial cells. Its mitotic activity is mainly manifested in keratinocytes, which can specifically promote the proliferation, migration and differentiation of epithelial cells. It is closely related to organ development, wound repair, tumor genesis and immune reconstruction.Activity definition: The ED50 value is less than 1.0 ng/ml, that is, the corresponding activity unit is greater than or equal to 1 x 10*6 units/mg, as determined by the proliferation method of cultured MCF-7 cells... Read More |